Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label active-controlled non-inferiority study of NPC-25 vs NOBELZIN in hypozincemia
jRCT2071210102Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of zinc histidine hydrate in zinc deficiency (2 arms), sponsored by Nobelpharma Co., Ltd. Started Jan 2022; status: completed.
02
Drugs
zinc histidine hydrate
03
Conditions
zinc deficiency
Beyond the preview
Go deeper on jRCT2071210102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210102.